Fruit‐Derived Extracellular‐Vesicle‐Engineered Structural Droplet Drugs for Enhanced Glioblastoma Chemotherapy
Advanced Materials · 2023-11 · 35 (45)
DOI: 10.1002/adma.202304187 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 08.10.2023. Verfasst von Jianping Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Research Institute, Experimental Education/Administration Center, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 51…. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms. Die Arbeit wurde bisher 94-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Existing solid‐nanoparticle‐based drug delivery systems remain a great challenge for glioblastoma chemotherapy due to their poor capacities in crossing the blood–brain barrier/blood–brain tumor barrier (BBB/BBTB). Herein, fruit‐derived extracellular‐vesicle (EV)‐engineered structural droplet drugs (ESDDs) are demonstrated by programming the self‐assembly of fruit‐derived EVs at the DOX@squalene–PBS interface, greatly enhancing the antitumor efficacy against glioblastoma. The ESDDs experience a flexible delivery via deformation‐amplified macropinocytosis and membrane fusion, enabling them to highly efficiently cross the BBB/BBTB and deeply penetrate glioblastoma tissues. As expected, the ESDDs exhibit approximately 2.5‐fold intracellular uptake, 2.2‐fold transcytosis, and fivefold membrane fusion higher than cRGD‐modified EVs (REs), allowing highly efficient accumulation, deep penetration, and cellular internalization into the glioblastoma tissues, and thereby significantly extending the survival time of glioblastoma mice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Research Institute, Experimental Education/Administration Center, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, P. R. China.
- Department of Radiotherapy, The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People's Hospital, Qingyuan, Guangdong, 511518, P. R. China.
ORCID-Profile: Ying Wang, Jun-Bing Fan
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
Zitieren
APA
Chen, J., Pan, J., Liu, S., Zhang, Y., Sha, S., Guo, H., Wang, X., Hao, X., Zhou, H., Tao, S., Wang, Y., & Fan, J. B. (2023). Fruit‐Derived Extracellular‐Vesicle‐Engineered Structural Droplet Drugs for Enhanced Glioblastoma Chemotherapy. Advanced Materials, 35(45). https://doi.org/10.1002/adma.202304187
Vancouver
Chen J, Pan J, Liu S, Zhang Y, Sha S, Guo H, et al. Fruit‐Derived Extracellular‐Vesicle‐Engineered Structural Droplet Drugs for Enhanced Glioblastoma Chemotherapy. Advanced Materials. 2023;35(45). doi:10.1002/adma.202304187
BibTeX
@article{Chen2023,
author = {Chen, Jianping and Pan, Jiahao and Liu, Sijia and Zhang, Yangning and Sha, Suinan and Guo, Haoyan and Wang, Xuejiao and Hao, Xiangrong and Zhou, Houwang and Tao, Sijian and Wang, Ying and Fan, Jun-Bing},
title = {Fruit‐Derived Extracellular‐Vesicle‐Engineered Structural Droplet Drugs for Enhanced Glioblastoma Chemotherapy},
journal = {Advanced Materials},
year = {2023},
volume = {35},
number = {45},
doi = {10.1002/adma.202304187}
}
EUVIMED